Wells Fargo Maintains an 'Outperform' on Cisco (CSCO); Raising Numbers on Execution and Payout
Get Alerts CSCO Hot Sheet
Price: $48.10 -0.52%
Rating Summary:
27 Buy, 29 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
27 Buy, 29 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Wells Fargo maintains an 'Outperform' on Cisco (NASDAQ: CSCO) price target range raised to $21-$23 (from $20-$22).
Analyst, Jess Lubert, said, "Cisco delivered slightly better-than-expected FQ4 results and guided mostly inline for the October period, excluding the impact of NDS. We believe the results and outlook were better than feared as improved execution and several strong product cycles appear to be benefiting share."
"With Cisco executing well and now offering an attractive combination of growth and yield relative to other large cap peers, we see value in the stock at current levels. Post FQ4 results, we raise our FY2013 EPS from $1.93 to $1.97 and introduce our F2014 EPS of $2.21."
For an analyst ratings summary and ratings history on Cisco click here. For more ratings news on Cisco click here.
Shares of Cisco closed at $17.35 yesterday.
Analyst, Jess Lubert, said, "Cisco delivered slightly better-than-expected FQ4 results and guided mostly inline for the October period, excluding the impact of NDS. We believe the results and outlook were better than feared as improved execution and several strong product cycles appear to be benefiting share."
"With Cisco executing well and now offering an attractive combination of growth and yield relative to other large cap peers, we see value in the stock at current levels. Post FQ4 results, we raise our FY2013 EPS from $1.93 to $1.97 and introduce our F2014 EPS of $2.21."
For an analyst ratings summary and ratings history on Cisco click here. For more ratings news on Cisco click here.
Shares of Cisco closed at $17.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MarineMax (HZO) PT Lowered to $35 at Stifel
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
- Chugai Pharmaceutical (4519:JP) PT Lowered to JPY5,200 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!